Raymond James Financial
NSPR icon

Raymond James Financial’s InspireMD NSPR Stock Holding History

Raymond James Financial’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-44,604
Closed -$101K – 6131
2025
Q2 		$101K Buy
44,604
+10,000
+29% +$24.9K ﹤0.01% 4865
2025
Q1 		$93.1K Buy
+34,604
New +$97.9K ﹤0.01% 4554

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Raymond James Financial's NSPR Position: Q3 2025 in Review

Raymond James Financial sold out of InspireMD (NSPR) in Q3 2025, closing a stake of 44,604 shares — an estimated $101K sold.

Raymond James Financial first reported a position in NSPR in Q1 2025 and held it in 2 quarters. The position peaked at $101K in Q2 2025. 41 funds tracked by Wall St. Rank hold NSPR as of Q3 2025.

  • Raymond James Financial reported no remaining InspireMD position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 44,604 InspireMD shares in Q3 2025, an estimated $101K.
  • Raymond James Financial first reported a position in InspireMD in Q1 2025 and held it in 2 quarters.
  • Raymond James Financial's InspireMD position peaked at $101K in Q2 2025.
  • 41 funds tracked by Wall St. Rank held InspireMD as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.